Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Aaron's Company, Inc. stock logo
AAN
Aaron's
$7.32
-1.5%
$7.81
$6.72
$16.16
$230.51M1.31268,456 shs181,576 shs
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
$136.93
-4.4%
$149.15
$66.03
$161.00
$7.97B0.5368,318 shs366,671 shs
Cencora, Inc. stock logo
COR
Cencora
$239.76
+0.8%
$238.24
$163.37
$246.75
$47.83B0.451.26 million shs831,205 shs
ION Geophysical Co. stock logo
IO
ION Geophysical
$0.54
$0.30
$2.67
$10.37M3.384.65 million shs16,621 shs
NVV
Norvista Capital
C$0.08
-6.3%
C$0.08
C$0.07
C$0.23
C$5.26MN/A116,000 shs112,500 shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Aaron's Company, Inc. stock logo
AAN
Aaron's
+1.22%+4.86%+1.64%-30.63%-41.05%
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
-1.14%+0.71%-0.89%+8.68%+82.72%
Cencora, Inc. stock logo
COR
Cencora
+0.09%-0.27%-1.70%+8.73%+41.56%
ION Geophysical Co. stock logo
IO
ION Geophysical
0.00%0.00%0.00%0.00%0.00%
NVV
Norvista Capital
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Aaron's Company, Inc. stock logo
AAN
Aaron's
4.0505 of 5 stars
3.23.04.20.00.61.73.1
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
2.1337 of 5 stars
4.40.00.00.01.81.70.6
Cencora, Inc. stock logo
COR
Cencora
3.8333 of 5 stars
1.32.01.73.12.53.32.5
ION Geophysical Co. stock logo
IO
ION Geophysical
N/AN/AN/AN/AN/AN/AN/AN/A
NVV
Norvista Capital
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Aaron's Company, Inc. stock logo
AAN
Aaron's
2.33
Hold$11.6759.38% Upside
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
2.88
Moderate Buy$173.2526.52% Upside
Cencora, Inc. stock logo
COR
Cencora
2.63
Moderate Buy$218.22-8.98% Downside
ION Geophysical Co. stock logo
IO
ION Geophysical
N/AN/AN/AN/A
NVV
Norvista Capital
N/AN/AN/AN/A

Current Analyst Ratings

Latest AAN, IO, ASND, COR, and NVV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$116.00 ➝ $116.00
4/18/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$173.00
4/2/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$165.00 ➝ $167.00
4/1/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$173.00
3/15/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$196.00 ➝ $260.00
3/11/2024
The Aaron's Company, Inc. stock logo
AAN
Aaron's
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold$7.00
3/8/2024
The Aaron's Company, Inc. stock logo
AAN
Aaron's
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform$7.00
2/28/2024
The Aaron's Company, Inc. stock logo
AAN
Aaron's
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$12.00 ➝ $9.00
2/26/2024
Cencora, Inc. stock logo
COR
Cencora
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024
Cencora, Inc. stock logo
COR
Cencora
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$261.00
2/8/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$146.00 ➝ $182.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Aaron's Company, Inc. stock logo
AAN
Aaron's
$2.14B0.11$18.77 per share0.39$22.62 per share0.32
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
$288.08M27.67N/AN/A($2.73) per share-50.16
Cencora, Inc. stock logo
COR
Cencora
$262.17B0.18$17.25 per share13.90$3.32 per share72.22
ION Geophysical Co. stock logo
IO
ION Geophysical
$122.67M0.00N/AN/A($4.75) per share0.00
NVV
Norvista Capital
C$-1.27M-4.13C$0.12 per share0.63C$0.11 per share0.67

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Aaron's Company, Inc. stock logo
AAN
Aaron's
$2.82M$0.0891.5010.93N/A0.13%3.59%1.38%5/6/2024 (Confirmed)
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
-$521.07M-$9.25N/AN/AN/A-180.61%-16,574.15%-55.10%4/25/2024 (Estimated)
Cencora, Inc. stock logo
COR
Cencora
$1.75B$9.1826.1216.381.810.69%323.23%4.13%5/1/2024 (Confirmed)
ION Geophysical Co. stock logo
IO
ION Geophysical
-$37.22M-$2.30N/AN/AN/A-42.05%N/A-17.35%N/A
NVV
Norvista Capital
N/A-C$0.05N/AN/AN/AN/AN/AN/A

Latest AAN, IO, ASND, COR, and NVV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2024N/A
The Aaron's Company, Inc. stock logo
AAN
Aaron's
-$0.08N/A+$0.08N/AN/AN/A  
5/1/2024N/A
Cencora, Inc. stock logo
COR
Cencora
$3.65N/A-$3.65N/AN/AN/A  
4/25/2024N/A
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/A-$1.60-$1.60N/AN/AN/A
2/27/2024Q4 2023
The Aaron's Company, Inc. stock logo
AAN
Aaron's
$0.03-$0.26-$0.29-$0.11$542.07 million$529.50 million    
2/7/2024Q4 2023
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
-$2.15-$1.66+$0.49-$1.66$97.02 million$148.62 million
1/31/202412/31/2023
Cencora, Inc. stock logo
COR
Cencora
$2.86$3.28+$0.42$3.58$68.81 billion$72.25 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Aaron's Company, Inc. stock logo
AAN
Aaron's
$0.506.83%+44.71%625.00%13 Years
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/AN/AN/AN/AN/A
Cencora, Inc. stock logo
COR
Cencora
$2.040.85%-33.19%22.22%1 Years
ION Geophysical Co. stock logo
IO
ION Geophysical
N/AN/AN/AN/AN/A
NVV
Norvista Capital
N/AN/AN/AN/AN/A

Latest AAN, IO, ASND, COR, and NVV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/26/2024
The Aaron's Company, Inc. stock logo
AAN
Aaron's
Quarterly$0.12505.87%3/13/20243/14/20244/3/2024
1/31/2024
Cencora, Inc. stock logo
COR
Cencora
quarterly$0.510.93%2/8/20242/9/20242/26/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Aaron's Company, Inc. stock logo
AAN
Aaron's
0.28
1.04
0.73
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/A
3.56
2.50
Cencora, Inc. stock logo
COR
Cencora
3.94
0.88
0.52
ION Geophysical Co. stock logo
IO
ION Geophysical
N/A
0.64
0.55
NVV
Norvista Capital
0.07
11.62
11.58

Ownership

Institutional Ownership

CompanyInstitutional Ownership
The Aaron's Company, Inc. stock logo
AAN
Aaron's
91.99%
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/A
Cencora, Inc. stock logo
COR
Cencora
97.52%
ION Geophysical Co. stock logo
IO
ION Geophysical
16.49%
NVV
Norvista Capital
N/A

Insider Ownership

CompanyInsider Ownership
The Aaron's Company, Inc. stock logo
AAN
Aaron's
3.50%
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
40.00%
Cencora, Inc. stock logo
COR
Cencora
15.80%
ION Geophysical Co. stock logo
IO
ION Geophysical
8.30%
NVV
Norvista Capital
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
The Aaron's Company, Inc. stock logo
AAN
Aaron's
9,07131.49 million30.38 millionOptionable
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
87958.22 million34.93 millionOptionable
Cencora, Inc. stock logo
COR
Cencora
46,000199.48 million167.96 millionOptionable
ION Geophysical Co. stock logo
IO
ION Geophysical
36029.62 million27.16 millionOptionable
NVV
Norvista Capital
N/A70.14 millionN/ANot Optionable

AAN, IO, ASND, COR, and NVV Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Aaron

Aaron's

NYSE:AAN
Headquartered in Atlanta, The Aaron's Company, Inc. (NYSE: AAN) is a leading, technology-enabled, omnichannel provider of lease-purchase solutions. Aaron's engages in direct-to-consumer sales and lease ownership of furniture, appliances, consumer electronics and accessories through its approximately 1,300 company-operated and franchised stores in 47 states and Canada, as well as its e-commerce platform, Aarons.com. For more information, visit Aarons.com or investor.aarons.com.
Ascendis Pharma A/S logo

Ascendis Pharma A/S

NASDAQ:ASND
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
Cencora logo

Cencora

NYSE:COR
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
ION Geophysical logo

ION Geophysical

NYSE:IO
ION Geophysical Corporation provides data-driven decision-making to offshore energy, and ports, and defense industries worldwide. The company operates through two segments, E&P Technology & Services and Operations Optimization. The E&P Technology & Services segment creates digital data assets and delivers services to help E&P companies improve decision-making and reduce risk. This segment includes two synergistic groups, imaging and reservoir services, and ventures. The company's Imaging and Reservoir Services group provides data processing, imaging, and reservoir services that improve image quality and subsurface insights, helping E&P companies reduce exploration and production risk, evaluate and develop reservoirs, and increase production. Its Imaging and Reservoir Services group develops and applies proprietary processing algorithms through its imaging engine to data owned or licensed by its customers to translate raw data into subsurface images. The Operations Optimization segment develops mission-critical subscription offerings and provides engineering services that enable operational control and optimization offshore. This segment includes the company's Optimization Software & Services and Devices offerings. The company's Optimization Software & Services group provides survey design, command, and control software systems and related services for marine towed streamer and seabed operations. Its Devices offerings group develops intelligent equipment controlled by its software to optimize operations. The company sells its services and products through a direct sales force consisting of employees and international third-party sales representatives. ION Geophysical Corporation was formerly known as Input/Output, Inc. and changed its name to ION Geophysical Corporation in 2007. The company was founded in 1968 and is headquartered in Houston, Texas. On April 12, 2022, ION Geophysical Corporation along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.

Norvista Capital

CVE:NVV
Norvista Capital Corporation operates as a resource investment company and merchant bank in the United States and Canada. It invests in a portfolio of companies that are involved in the exploration of base and precious metals, such as copper, zinc, silver, gold, and lead, as well as oil and gas located in Chile, Manitoba, Yukon, Mexico, and Nevada; and oil and gas in Israel, the United States, Brazil, and Canada. The company was founded in 2014 and is headquartered in Toronto, Canada.